Product
LBL-003Injection
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of LBL-003 Injection in Patients With Advanced MalignanciesStatus: Recruiting, Estimated PCD: 2024-03-22